Clinical Trial Update: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Ponsegromab in adults with cachexia due to metastatic pancreatic ductal adenocarcinoma (phases 2 and 3) currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Ponsegromab

Snippet

Sponsor: Pfizer | Conditions: Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2, Phase 3 | Status: RECRUITING